logo
Select company
Select metric
-2.77%EBITDA Margin
VS
Market
27
Sector
60
Industry
64
History
100
$ 1.53Close
$ 1.16 - $ 2.15 52-Week Range
Ticker Information

Ticker

CERS

Company Name

CERUS CORP

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

CERUS CORP - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CERS - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -5.98M-2.77%$ 216.39M
3/31/2025$ -5.95M-2.88%$ 206.78M
12/31/2024$ -7.5M-3.72%$ 201.32M
9/30/2024$ -5.66M-2.86%$ 197.91M
6/30/2024$ -9.82M-5.05%$ 194.51M
3/31/2024$ -17.2M-8.97%$ 191.72M
12/31/2023$ -23.87M-12.78%$ 186.8M
9/30/2023$ -36.7M-19.86%$ 184.78M
6/30/2023$ -39.03M-21.23%$ 183.87M
3/31/2023$ -35.16M-19.13%$ 183.77M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CERUS CORP's latest trailing twelve months (TTM) EBITDA % stands at -50.52%.
  • Over the past 5 years, CERUS CORP's average EBITDA % has been -20.67%.
  • The median EBITDA % for CERUS CORP during this period was -18.31%
  • CERUS CORP reached its highest EBITDA % over the past 5 years at -2.77%.
  • The lowest EBITDA % recorded by CERUS CORP in the same timeframe -50.52%

CERUS CORP's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
VMD : VIEMED HEALTHCARE INC 19.54%QTRX : QUANTERIX CORP -50.82%TMCI : TREACE MEDICAL CONCEPTS INC -15.06%OM : OUTSET MEDICAL INC -60.2%TCMD : TACTILE SYSTEMS TECHNOLOGY INC 10.18%RXST : RXSIGHT INC -19.67%VNDA : VANDA PHARMACEUTICALS INC -37.87%QIPT : QUIPT HOME MEDICAL CORP 20.93%MASS : 908 DEVICES INC -22.19%PACB : PACIFIC BIOSCIENCES OF CALIFORNIA INC -71.83%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for CERUS CORP is calculated as follows: EBITDA [ $ -54.13M ] / Revenues [ $ 107.15M ]
(=) EBITDA % [ -50.52% ]

CERS - EBITDA Margin, Last 5 years

-50.52%

Minimum

Sep 30, 2020

-2.77%

Maximum

Jun 30, 2025

-20.67%

Average

-18.31%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-75.07%
max97.73%
average16.12%
median14.72%
std26.88%